Unilife Receives Patent for Prefilled Syringe

Unilife Corp. has announced it has received a U.S. patient for its Unifill ready-to-fill (prefilled) syringe, according to a news release.

The patent covers Unilife's technology for the integration of automatic and operator-controlled needle retraction features within the barrel of a prefilled syringe, according to the company.

"The Unifill syringe is the world's first and only prefilled syringe with integrated safety features," said Alan Shortall, CEO of Unilife, in the release. "This patented technology differentiates Unifill from every other prefilled syringe that is either on the market, or known by us to be in development. It is a key component of our strong and fast-expanding intellectual property portfolio. The patent further validates the uniqueness of Unilife's proprietary integrated retraction technology."

Unilife Corp. has its U.S. headquarters in York, Pa.

Related Articles on New Technology:

TriReme Medical Receives FDA Clearance for Expanded Sizes of PTA Balloon Catheter

Medtronic Receives Expanded FDA Clearance for Pillar Palatal Implant System

St. Jude Receives FDA Clearance for Ultrasound Catheter

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.